HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frequency of HLA-B27 alleles in Brazilian patients with psoriatic arthritis.

Abstract
This prospective study analyzed the frequency of HLA-B27 and its alleles in 102 Brazilian patients with psoriatic arthritis (PsA). The association of the HLA-B27 alleles with these variants was compared to a control healthy HLA-B27 positive group of 111 individuals. There was a predominance of male gender (59.8%), Caucasian race (89.2%), and negative HLA-B27 (79.4%) patients. Asymmetric oligoarthritis (62.7%) was the most frequently observed clinical PsA subgroup, followed by spondylitis (16.7%), and polyarthritis (15.7%). Male gender and the spondylitis subgroup were statistically associated to the positive HLA-B27, and the oligoarthritis subgroup was associated to the negative HLA-B27. Among the 21 HLA-B27-positive PsA patients, there was a significant prevalence of the HLA-B*2705 allele (90.5%), similar to that observed in the control group (80.2%); HLA-B*2703 and HLA-B*2707 were statistically associated to the control group.
AuthorsRubens Bonfiglioli, Roseneide A Conde, Percival D Sampaio-Barros, Paulo Louzada-Junior, Eduardo A Donadi, Manoel B Bertolo
JournalClinical rheumatology (Clin Rheumatol) Vol. 27 Issue 6 Pg. 709-12 (Jun 2008) ISSN: 0770-3198 [Print] Germany
PMID17982707 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-B27 Antigen
Topics
  • Adult
  • Alleles
  • Arthritis, Psoriatic (ethnology, genetics)
  • Black People (statistics & numerical data)
  • Brazil (epidemiology)
  • Female
  • Genetic Predisposition to Disease (ethnology)
  • HLA-B27 Antigen (genetics)
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • White People (statistics & numerical data)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: